Lipoprotein-Associated Phospholipase A2 and Measures of Extracoronary Atherosclerosis
- 1 March 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (3) , 631-636
- https://doi.org/10.1161/01.atv.0000201289.83256.cf
Abstract
Objective— Lipoprotein-associated phospholipase A2 (Lp-PLA2) may be a new and independent predictor of cardiovascular events. The effect of Lp-PLA2 may be exerted through effects of the enzyme on the development of atherosclerosis. Therefore, we investigated the association between Lp-PLA2 activity and measures of extracoronary atherosclerosis. Methods and Results— Lp-PLA2 activity was determined in a random sample of 1820 participants from the Rotterdam Study, a population-based cohort study in men and women ≥55 years. Common carotid intima-media thickness, carotid plaques, ankle-arm index, and aortic calcification were examined. Atherosclerosis status could be assigned in 1609 participants. The age-adjusted odds ratio of having atherosclerosis at any site for the highest versus the lowest tertile of Lp-PLA2 activity was 1.86 (95% CI, 1.01 to 3.43) in men and 1.60 (95% CI, 1.08 to 2.37) in women. After additional adjustment for cholesterol, these associations attenuated or even disappeared. The odds ratios of having atherosclerosis at specific sites (carotid arteries and aortic-iliac-femoral tract) followed a similar pattern. Conclusions— Although Lp-PLA2 has been found to be independently associated with cardiovascular events, the association with measures of subclinical extracoronary atherosclerosis found in this study strongly attenuated or even disappeared after adjustment for cholesterol.Keywords
This publication has 26 references indexed in Scilit:
- Association between Lp-PLA2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasisAtherosclerosis, 2005
- Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk FactorsCirculation, 2005
- Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic StrokeCirculation, 2005
- Association of Lipoprotein-Associated Phospholipase A 2 Mass and Activity With Calcified Coronary Plaque in Young AdultsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-upEuropean Heart Journal, 2004
- Platelet-Activating Factor Acetylhydrolase Is Not Associated with Carotid Intima-Media Thickness in Hypercholesterolemic Sicilian IndividualsClinical Chemistry, 2004
- Lipoprotein-Associated Phospholipase A 2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General PopulationCirculation, 2004
- Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysisJournal of Lipid Research, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Inflammatory Mediators and Cell Adhesion Molecules as Indicators of Severity of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2002